Effects of protein kinase A and G inhibitors on hippocampal cholinergic markers expressions in rolipram- and sildenafil-induced spatial memory improvement

Pharmacology Biochemistry and Behavior

Volumn 101, Issue 3, 2012, Pages 311-319

  Hosseini Sharifabad, Ali ^b   Ghahremani, Mohammad Hossein ^a   Sabzevari, Omid ^a   Naghdi, Naser ^c   Abdollahi, Mohammad ^a   Beyer, Cordian ^d   Bollen, Eva ^e   Prickaerts, Jos ^e   Roghani, Ali ^f   Sharifzadeh, Mohammad ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID SADOUGHI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c PASTEUR INSTITUTE OF IRAN   (Iran)

^d RWTH AACHEN UNIVERSITY   (Germany)

^e MAASTRICHT UNIVERSITY   (Netherlands)

^f TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER SCHOOL OF MEDICINE   (United States)

Author keywords

ChAT; PKA; PKG; Rolipram; Sildenafil; Spatial consolidation; VAChT

Indexed keywords

CHOLINE ACETYLTRANSFERASE; KT 5823; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; ROLIPRAM; SILDENAFIL; VESICULAR ACETYLCHOLINE TRANSPORTER;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHOLINERGIC ACTIVITY; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; HIPPOCAMPUS; MALE; MEMORY CONSOLIDATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SPATIAL MEMORY;

ACETYLCHOLINE; ANIMALS; CHOLINE O-ACETYLTRANSFERASE; CYCLIC AMP-DEPENDENT PROTEIN KINASES; CYCLIC GMP-DEPENDENT PROTEIN KINASES; DRUG INTERACTIONS; HIPPOCAMPUS; MALE; MAZE LEARNING; MEMORY; PHOSPHODIESTERASE 4 INHIBITORS; PHOSPHODIESTERASE 5 INHIBITORS; PIPERAZINES; PROTEIN KINASE INHIBITORS; PURINES; RATS; RATS, WISTAR; ROLIPRAM; SIGNAL TRANSDUCTION; SULFONES; VESICULAR ACETYLCHOLINE TRANSPORT PROTEINS;

RATTUS;

EID: 84856985350     PISSN: 00913057     EISSN: 18735177     Source Type: Journal    
DOI: 10.1016/j.pbb.2012.01.017     Document Type: Article

References (55)

1. Abdollahi M, Fooladian F, Emami B, Zafari K, Bahreini-Moghadam A. Protection by sildenafil and theophylline of lead acetate-induced oxidative stress in rat submandibular gland and saliva. Hum Exp Toxicol 2003;22:587-92. (Pubitemid 37536777)
2. Antoine C, Antoine P, Guermonprez P, Frigard B. Awareness of deficits and anosognosia in Alzheimer's disease. Encéphale 2004;30:570-7.
3. Auld DS, Kornecook TJ, Bastianetto S, Quirion R. Alzheimer's disease and the basal forebrain cholinergic system: relations to beta-amyloid peptides, cognition, and treatment strategies. Prog Neurobiol 2002;68:209-45. (Pubitemid 35346805)
4. Azami K, Etminani M, Tabrizian K, Salar F, Belaran M, Hosseini A, et al. The quantitative evaluation of cholinergic markers in spatial memory improvement induced by nicotine-bucladesine combination in rats. Eur J Pharmacol 2010;636:102-7.
5. Barad M, Bourtchouladze R, Winder DG, Golan H, Kandel E. Rolipram, a type IV-specific phosphodiesterase inhibitor, facilitates the establishment of long-lasting long-term potentiation and improves memory. Proc Natl Acad Sci U S A 1998;95: 15020-5. (Pubitemid 29003749)
6. Baratti CM, Boccia MM. Effects of sildenafil on long-term retention of an inhibitory avoidance response in mice. Behav Pharmacol 1999;10:731-7. (Pubitemid 30028747)
7. Bartus RT, Dean III RL, Beer B, Lippa AS. The cholinergic hypothesis of geriatric memory dysfunction. Science 1982;217:408-14.
8. Bender AT, Beavo JA. Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use. Pharmacol Rev 2006;58:488-520. (Pubitemid 44394910)
9. Bernabeu R, Bevilaqua L, Ardenghi P, Bromberg E, Schmitz P, Bianchin M, et al. Involvement of hippocampal cAMP/cAMP-dependent protein kinase signaling pathways in a late memory consolidation phase of aversively motivated learning in rats. Proc Natl Acad Sci U S A 1997a;94:7041-6. (Pubitemid 27281987)
10. Bernabeu R, Schroder N, Quevedo J, Cammarota M, Izquierdo I, Medina JH. Further evidence for the involvement of a hippocampal cGMP/cGMP-dependent protein kinase cascade in memory consolidation. Neuroreport 1997b;8:2221-4. (Pubitemid 27319676)
11. Bliss TV, Collingridge GL. A synaptic model of memory: long-term potentiation in the hippocampus. Nature 1993;361:31-9. (Pubitemid 23020772)
12. Bliss TV, Lomo T. Long-lasting potentiation of synaptic transmission in the dentate area of the anaesthetized rabbit following stimulation of the perforant path. J Physiol 1973;232:331-56.
13. Blokland A, Schreiber R, Prickaerts J. Improving memory: a role for phosphodiesterases. Curr Pharm Des 2006;12:2511-23.
14. Boess FG, Hendrix M, van der Staay FJ, Erb C, Schreiber R, van Staveren W, et al. Inhibition of phosphodiesterase 2 increases neuronal cGMP, synaptic plasticity and memory performance. Neuropharmacology 2004;47:1081-92. (Pubitemid 39535847)
15. Bolshakov VY, Golan H, Kandel ER, Siegelbaum SA. Recruitment of new sites of synaptic transmission during the cAMP-dependent late phase of LTP at CA3-CA1 synapses in the hippocampus. Neuron 1997;19:635-51. (Pubitemid 27430750)
16. Boswell-Smith V, Spina D, Page CP. Phosphodiesterase inhibitors. Br J Pharmacol 2006;147(Suppl. 1):S252-7. (Pubitemid 43077283)
17. Boulton CL, Southam E, Garthwaite J. Nitric oxide-dependent long-term potentiation is blocked by a specific inhibitor of soluble guanylyl cyclase. Neuroscience 1995;69: 699-703.
18. Campbell E, Edwards T. Zaprinast consolidates long-term memory when administered to neonate chicks trained using a weakly reinforced single trial passive avoidance task. Behav Brain Res 2006;169:181-5. (Pubitemid 43277485)
19. Choopani S, Moosavi M, Naghdi N. Involvement of nitric oxide in insulin induced memory improvement. Peptides 2008;29:898-903.
20. Devan BD, Sierra-Mercado Jr D, Jimenez M, Bowker JL, Duffy KB, Spangler EL, et al. Phosphodiesterase inhibition by sildenafil citrate attenuates the learning impairment induced by blockade of cholinergic muscarinic receptors in rats. Pharmacol Biochem Behav 2004;79:691-9. (Pubitemid 39600608)
21. Drever BD, Riedel G, Platt B. The cholinergic system and hippocampal plasticity. Behav Brain Res 2011;221:505-14.
22. Egawa T, Mishima K, Matsumoto Y, Iwasaki K, Fujiwara M. Rolipram and its optical isomers, phosphodiesterase 4 inhibitors, attenuated the scopolamine-induced impairments of learning and memory in rats. Jpn J Pharmacol 1997;75:275-81. (Pubitemid 28000172)
23. Ferrari F, Ottani A, Giuliani D. Influence of sildenafil on central dopamine-mediated behaviour in male rats. Life Sci 2002;70:1501-8. (Pubitemid 34164544)
24. Frey U, Huang YY, Kandel ER. Effects of cAMP simulate a late stage of LTP in hippocampal CA1 neurons. Science 1993;260:1661-4. (Pubitemid 23247151)
25. Gong B, Vitolo OV, Trinchese F, Liu S, Shelanski M, Arancio O. Persistent improvement in synaptic and cognitive functions in an Alzheimer mouse model after rolipram treatment. J Clin Invest 2004;114:1624-34. (Pubitemid 40385553)
26. Hosseini-Sharifabad A, Mohammadi-Eraghi S, Tabrizian K, Soodi A, Khorshidahmad T, Naghdi N, et al. Effects of training in the Morris water maze on the spatial learning acquisition and VAChT expression in male rats. DARU 2011;19:166-72.
27. Izquierdo I, Bevilaqua LR, Rossato JI, Bonini JS, Medina JH, Cammarota M. Different molecular cascades in different sites of the brain control memory consolidation. Trends Neurosci 2006;29:496-505. (Pubitemid 44291818)
28. Kleppisch T, Feil R. cGMP signalling in the mammalian brain: role in synaptic plasticity and behaviour. Handb Exp Pharmacol 2009:549-79.
29. Lakics V, Karran EH, Boess FG. Quantitative comparison of phosphodiesterase mRNA distribution in human brain and peripheral tissues. Neuropharmacology 2010;59:367-74.
30. Matsumoto Y, Hatano A, Unoki S, Mizunami M. Stimulation of the cAMP system by the nitric oxide-cGMP system underlying the formation of long-term memory in an insect. Neurosci Lett 2009;467:81-5.
31. Monfort P, Munoz MD, Kosenko E, Felipo V. Long-term potentiation in hippocampus involves sequential activation of soluble guanylate cyclase, cGMP-dependent protein kinase, and cGMP-degrading phosphodiesterase. J Neurosci 2002;22: 10116-22. (Pubitemid 35416850)
32. Nguyen PV, Abel T, Kandel ER. Requirement of a critical period of transcription for induction of a late phase of LTP. Science 1994;265:1104-7. (Pubitemid 24293080)
33. Parent MB, Baxter MG. Septohippocampal acetylcholine: involved in but not necessary for learning and memory? Learn Mem 2004;11:9-20. (Pubitemid 38167053)
34. Paxinos G, Watson CR, Emson PC. AChE-stained horizontal sections of the rat brain in stereotaxic coordinates. J Neurosci Methods 1980;3:129-49. (Pubitemid 11162950)
35. Prickaerts J, de Vente J, Honig W, Steinbusch HW, Blokland A. cGMP, but not cAMP, in rat hippocampus is involved in early stages of object memory consolidation. Eur J Pharmacol 2002a;436:83-7. (Pubitemid 34142401)
36. Prickaerts J, van Staveren WC, Sik A, Markerink-van Ittersum M, Niewohner U, van der Staay FJ, et al. Effects of two selective phosphodiesterase type 5 inhibitors, sildenafil and vardenafil, on object recognition memory and hippocampal cyclic GMP levels in the rat. Neuroscience 2002b;113:351-61. (Pubitemid 34786180)
37. Prickaerts J, Sik A, van Staveren WC, Koopmans G, Steinbusch HW, van der Staay FJ, et al. Phosphodiesterase type 5 inhibition improves early memory consolidation of object information. Neurochem Int 2004;45:915-28. (Pubitemid 39108064)
38. Prickaerts J, Sik A, van der Staay FJ, de Vente J, Blokland A. Dissociable effects of acetylcholinesterase inhibitors and phosphodiesterase type 5 inhibitors on object recognition memory: acquisition versus consolidation. Psychopharmacology (Berl) 2005;177:381-90. (Pubitemid 40228285)
39. Puzzo D, Staniszewski A, Deng SX, Privitera L, Leznik E, Liu S, et al. Phosphodiesterase 5 inhibition improves synaptic function, memory, and amyloid-beta load in an Alzheimer's disease mouse model. J Neurosci 2009;29:8075-86.
40. Reneerkens OA, Rutten K, Steinbusch HW, Blokland A, Prickaerts J. Selective phosphodiesterase inhibitors: a promising target for cognition enhancement. Psychopharmacology (Berl) 2009;202:419-43.
41. Rutten K, Vente JD, Sik A, Ittersum MM, Prickaerts J, Blokland A. The selective PDE5 inhibitor, sildenafil, improves object memory in Swiss mice and increases cGMP levels in hippocampal slices. Behav Brain Res 2005;164:11-6. (Pubitemid 41253727)
42. Rutten K, Prickaerts J, Blokland A. Rolipram reverses scopolamine-induced and time-dependent memory deficits in object recognition by different mechanisms of action. Neurobiol Learn Mem 2006;85:132-8. (Pubitemid 43247839)
43. Rutten K, Prickaerts J, Hendrix M, van der Staay FJ, Sik A, Blokland A. Time-dependent involvement of cAMP and cGMP in consolidation of object memory: studies using selective phosphodiesterase type 2, 4 and 5 inhibitors. Eur J Pharmacol 2007;558: 107-12. (Pubitemid 46328881)
44. Rutten K, Basile JL, Prickaerts J, Blokland A, Vivian JA. Selective PDE inhibitors rolipram and sildenafil improve object retrieval performance in adult cynomolgus macaques. Psychopharmacology (Berl) 2008;196:643-8.
45. Rutten K, Van Donkelaar EL, Ferrington L, Blokland A, Bollen E, Steinbusch HW, et al. Phosphodiesterase inhibitors enhance object memory independent of cerebral blood flow and glucose utilization in rats. Neuropsychopharmacology 2009;34: 1914-25.
46. Sharifzadeh M, Sharifzadeh K, Naghdi N, Ghahremani MH, Roghani A. Posttraining intrahippocampal infusion of a protein kinase AII inhibitor impairs spatial memory retention in rats. J Neurosci Res 2005;79:392-400. (Pubitemid 40278354)
47. Sharifzadeh M, Tavasoli M, Soodi M, Mohammadi-Eraghi S, Ghahremani MH, Roghani A. A time course analysis of cyclooxygenase-2 suggests a role in spatial memory retrieval in rats. Neurosci Res 2006;54:171-9. (Pubitemid 43276074)
48. Sharifzadeh M, Aghsami M, Gholizadeh S, Tabrizian K, Soodi M, Khalaj S, et al. Protective effects of chronic lithium treatment against spatial memory retention deficits induced by the protein kinase AII inhibitor H-89 in rats. Pharmacology 2007a;80:158-65. (Pubitemid 47230710)
49. Sharifzadeh M, Zamanian AR, Gholizadeh S, Tabrizian K, Etminani M, Khalaj S, et al. Post-training intrahippocampal infusion of nicotine-bucladesine combination causes a synergistic enhancement effect on spatial memory retention in rats. Eur J Pharmacol 2007b;562:212-20. (Pubitemid 46560501)
50. Terry Jr AV, Buccafusco JJ. The cholinergic hypothesis of age and Alzheimer's disease-related cognitive deficits: recent challenges and their implications for novel drug development. J Pharmacol Exp Ther 2003;306:821-7. (Pubitemid 37025286)
51. Terry Jr AV, Callahan PM, Hall B, Webster SJ. Alzheimer's disease and age-related memory decline (preclinical). Pharmacol Biochem Behav 2011;99:190-210.
52. Uthayathas S, Karuppagounder SS, Tamer SI, Parameshwaran K, Degim T, Suppiramaniam V, et al. Evaluation of neuroprotective and anti-fatigue effects of sildenafil. Life Sci 2007;81:988-92. (Pubitemid 47384783)
53. Zhang HT, Huang Y, Suvarna NU, Deng C, Crissman AM, Hopper AT, et al. Effects of the novel PDE4 inhibitors MEM1018 and MEM1091 on memory in the radial-arm maze and inhibitory avoidance tests in rats. Psychopharmacology (Berl) 2005;179:613-9. (Pubitemid 40674762)
54. Zhang RL, Zhang Z, Zhang L, Wang Y, Zhang C, Chopp M. Delayed treatment with sildenafil enhances neurogenesis and improves functional recovery in aged rats after focal cerebral ischemia. J Neurosci Res 2006;83:1213-9. (Pubitemid 43668004)
55. Zhuo M, Hu Y, Schultz C, Kandel ER, Hawkins RD. Role of guanylyl cyclase and cGMP-dependent protein kinase in long-term potentiation. Nature 1994;368: 635-9. (Pubitemid 24153387)